Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 680,358	$ (420,348)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	369,341	396,033
Long-lived asset impairment	0	436,908
Lower of cost or market inventory valuation adjustment	(318,862)	227,711
Earnings of equity method investments, inclusive of distributions	0	(238)
Loss on early extinguishment of debt	0	25,915
Gain on sales-type leases	0	(33,834)
Gain on sale of assets	(89,831)	(257)
Deferred income taxes	160,738	(147,283)
Equity-based compensation expense	29,663	22,221
Change in fair value – derivative instruments	(19,483)	(3,727)
(Increase) decrease in current assets:
Accounts receivable	(220,645)	325,796
Inventories	(399,630)	104,640
Income taxes receivable	(7,336)	(64,162)
Prepayments and other	10,369	14,403
Increase (decrease) in current liabilities:
Accounts payable	438,541	(387,259)
Income taxes payable	18,164	(21,379)
Accrued liabilities	215,817	(22,037)
Turnaround expenditures	(116,646)	(73,822)
Other, net	(11,064)	11,769
Net cash provided by operating activities	739,494	391,050
Cash flows from investing activities:
Additions to properties, plants and equipment	(471,412)	(174,366)
Proceeds from sale of assets	106,352	1,094
Distributions from equity method investments in excess of equity earnings	3,517	701
Net cash used for investing activities	(438,476)	(213,651)
Cash flows from financing activities:
Borrowings under credit agreements	210,500	219,500
Repayments under credit agreements	(283,500)	(237,000)
Proceeds from issuance of senior notes - HEP	0	748,925
Purchase of treasury stock	(613)	(3,350)
Dividends	(57,663)	(171,603)
Distributions to noncontrolling interests	(57,217)	(70,941)
Contributions from noncontrolling interests	21,285	15,382
Payments on finance leases	(2,047)	(2,149)
Deferred financing costs	(14,500)	(13,511)
Other, net	(414)	454
Net cash provided by (used for) financing activities	(184,169)	463,207
Effect of exchange rate on cash flow	(3,605)	(880)
Cash and cash equivalents:
Increase for the period	113,244	639,726
Beginning of period	1,368,318	885,162
End of period	1,481,562	1,524,888
Cash (paid) received during the period for:
Interest	(87,229)	(83,325)
Income taxes, net	20,959	(52,270)
Increase in accrued and unpaid capital expenditures	4,339	19,533
HEP
Cash flows from investing activities:
Additions to properties, plants and equipment	(76,933)	(38,642)
Investment in equity company - HEP	0	(2,438)
Cash flows from financing activities:
Proceeds from issuance of senior notes - HEP	0	500,000
Redemption of senior notes - HEP	$ 0	$ (522,500)